haxxiy on 22 February 2021
Excellent real-world results concerning the reduction of severe Covid-19 cases after the first dose, already in the first month:
Data for the Pfizer jab matches very well what we already have from Israel, so expect similar results as theirs after the second dose. As for the AZ vaccine, I suspect it will continue to increase before the delayed second dose from their, and J&J's, clinical trials, so all seems good.
